Conjunctival MicroRNA expression in inflammatory trachomatous scarring.

by Tamsyn Derrick, Chrissy h Roberts, Megha Rajasekhar, Sarah E Burr, Hassan Joof, Pateh Makalo, Robin L Bailey, David C W Mabey, Matthew J Burton, Martin J Holland
Published 2013-01-01

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

by Chrissy H Roberts, Sandra Molina, Pateh Makalo, Hassan Joof, Emma M Harding-Esch, Sarah E Burr, David C W Mabey, Robin L Bailey, Matthew J Burton, Martin J Holland
Published 2014-03-01

Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

by Matthew J Burton, Martin J Holland, Pateh Makalo, Esther A N Aryee, Ansumana Sillah, Sandra Cohuet, Angels Natividad, Neal D E Alexander, David C W Mabey, Robin L Bailey
Published 2010-10-01

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma

by Harry Pickering, Christine D. Palmer, Joanna Houghton, Pateh Makalo, Hassan Joof, Tamsyn Derrick, Adriana Goncalves, David C. W. Mabey, Robin L. Bailey, Matthew J. Burton, Chrissy H. Roberts, Sarah E. Burr, Sarah E. Burr, Martin J. Holland, Martin J. Holland
Published 2019-08-01

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.

by Emma M. Harding-Esch, Ansumana Sillah, Tansy Edwards, Sarah E. Burr, John D. Hart, Hassan Joof, Mass Laye, Pateh Makalo, Ahmed Manjang, Sandra Molina, Isatou Sarr-Sissoho, Thomas C. Quinn, Tom Lietman, Martin J. Holland, David Mabey, Sheila K. West, Robin Bailey
Published 2013-06-01

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.

by Stephanie J Migchelsen, Diana L Martin, Khamphoua Southisombath, Patrick Turyaguma, Anne Heggen, Peter Paul Rubangakene, Hassan Joof, Pateh Makalo, Gretchen Cooley, Sarah Gwyn, Anthony W Solomon, Martin J Holland, Paul Courtright, Rebecca Willis, Neal D E Alexander, David C W Mabey, Chrissy H Roberts
Published 2017-01-01

Responses of the putative trachoma vector, Musca sorbens, to volatile semiochemicals from human faeces.

by Ailie Robinson, Julie Bristow, Matthew V Holl, Pateh Makalo, Wondu Alemayehu, Robin L Bailey, David Macleod, Michael A Birkett, John C Caulfield, Virginia Sarah, John A Pickett, Sarah Dewhirst, Vanessa Chen-Hussey, Christine M Woodcock, Umberto D'Alessandro, Anna Last, Matthew J Burton, Steve W Lindsay, James G Logan
Published 2020-03-01

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.

by Emma M Harding-Esch, Ansumana Sillah, Tansy Edwards, Sarah E Burr, John D Hart, Hassan Joof, Mass Laye, Pateh Makalo, Ahmed Manjang, Sandra Molina, Isatou Sarr-Sissoho, Thomas C Quinn, Tom Lietman, Martin J Holland, David Mabey, Sheila K West, Robin Bailey, Partnership for Rapid Elimination of Trachoma (PRET) study group
Published 2013-01-01

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia

by Emma M. Harding-Esch, Ansumana Sillah, Tansy Edwards, Sarah E. Burr, John D. Hart, Hassan Joof, Mass Laye, Pateh Makalo, Ahmed Manjang, Sandra Molina, Isatou Sarr-Sissoho, Thomas C. Quinn, Tom Lietman, Martin J. Holland, David Mabey, Sheila K. West, Robin Bailey, on behalf of the Partnership for Rapid Elimination of Trachoma (PRET) study group
Published 2013-06-01